Trials / Completed
CompletedNCT05876026
MRI T1 Relaxation Time in Rectal Cancer
MRI T1 Relaxation Times in Evaluating Neoadjuvant Treatment of Rectal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Vejle Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the T1 relaxation time and T1 relaxation time properties of the disease in people with locally advanced rectal cancer. The main question it aims to answer is: Does MRI T1 relaxation time have a high diagnostic performance in recognizing fibrosis as a complete response to neoadjuvant treatment of rectal cancer? Participants will receive standard neoadjuvant treatment and be part of the standard examination programme regarding rectal cancer.
Conditions
Timeline
- Start date
- 2023-05-08
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
- First posted
- 2023-05-25
- Last updated
- 2026-01-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05876026. Inclusion in this directory is not an endorsement.